Galina Feinberg-Gorenshtein

Minimal Residual Disease in Peripheral Blood Stem Cell Harvests From High-risk Neuroblastoma Patients

I. Yaniv, S. Avigad, S. Ash, 2009, Journal of pediatric hematology/oncology.

Classifying Medulloblastoma Subgroups Based on Small, Clinically Achievable Gene Sets

H. Toledano, M. Salmon-Divon, Sivan Gershanov, 2021, Frontiers in Oncology.

Potential role of WSB1 isoforms in growth and survival of neuroblastoma cells

I. Yaniv, S. Avigad, K. Shichrur, 2014, Pediatric Research.

2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.

I. Yaniv, S. Avigad, J. Kapelushnik, 2010, The American journal of pathology.

Sporadic desmoid tumors in the pediatric population: A single center experience and review of the literature.

H. Toledano, I. Yaniv, S. Avigad, 2017, Journal of pediatric surgery.

miR-192 Directly Binds and Regulates Dicer1 Expression in Neuroblastoma

Abraham Weizman, N. Shomron, M. Feinmesser, 2013, PloS one.

Reduced levels of miR‐34a in neuroblastoma are not caused by mutations in the TP53 binding site

Abraham Weizman, I. Yaniv, S. Avigad, 2009, Genes, chromosomes & cancer.